Garheng Kong selected for Aspen Institute's Health Innovators Fellowship

Garheng Kong selected for Aspen Institute's Health Innovators Fellowship

HealthQuest Capital Managing Partner, Dr. Garheng Kong, was selected as one of 21 healthcare industry leaders to participate in the Aspen Insitute's Health Innovators Fellowship. He and the other fellows will participate in a two-year Fellowship designed to strengthen the leadership of innovators across the US health care ecosystem and challenge them to create new approaches to improve the health and well-being of all Americans.

 

HQC portfolio company Spirox acquired by Entellus

HQC portfolio company Spirox acquired by Entellus

Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that it has entered into a definitive agreement to acquire Spirox, Inc., a privately-held ENT medical technology company that develops, manufactures and markets the LATERA™ Absorbable Nasal Implant, a minimally invasive option for ENTs and facial plastic surgeons to treat nasal airway obstruction. 

Trice Medical Closes $19.3 Million Series C Financing

Trice Medical Closes $19.3 Million Series C Financing

Trice Medical announced today that it closed a $19.3 million Series C financing and will use the proceeds to accelerate and expand the company's U.S. market penetration for mi-eye2™, R&D, sales, marketing and key international regulatory approvals. Smith & Nephew (LSE:SN, NYSE: SNN) has taken a minority stake joining a consortium of current investors including HealthQuest.

HealthQuest's Garheng Kong named among "12 VC's That Matter But You Never Read About" by the Timmerman Report

HealthQuest's Garheng Kong named among "12 VC's That Matter But You Never Read About" by the Timmerman Report

The Timmerman Report, an independent publication focused on in-depth reporting in the biotech and medical technology space, recently named HealthQuest Managing Partner Garheng Kong in a profile article titled "12 VC's That Matter, But You Never Read About". The article quotes one CEO as saying "I've never met anyone as well-liked and connected as he is. Garheng taps those connections to help his portfolio companies and those far down the line, is always the smartest guy in the room, but doesn't have to remind you of that, seems to be way ahead of his peers in identifying trends."

HealthQuest Joins Syndicate for $42M Investment in Avedro

HealthQuest Joins Syndicate for $42M Investment in Avedro

Avedro, Inc., an ophthalmic pharmaceutical and medical device company and world leader in corneal remodeling, today announced that it secured a combined $42 million in equity and debt financing. The equity financing was led by HealthQuest Capital, with strong support from existing investors OrbiMed Advisors and InterWest Partners. 

Blue Cross/Blue Shield Issues Positive Assessment of Castle Bioscience Test

Blue Cross/Blue Shield Issues Positive Assessment of Castle Bioscience Test

Friendswood, TX – March 29, 2017 – Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced that Blue Cross Blue Shield Association Evidence Street™ has issued a positive assessment of DecisionDx®-UM, the Company’s gene expression profile (GEP) test to determine prognosis (metastatic potential) in patients diagnosed with uveal melanoma (UM). Evidence Street provides objective information to healthcare and managed care professionals based on clinical and scientific evidence and evaluates whether a technology could improve net health outcomes

Trice Medical's Mi-Eye Featured in Businessweek

Trice Medical's Mi-Eye Featured in Businessweek

Bloomberg Businessweek columnist Michael Belfiore featured Trice's Mi-Eye device as a key innovation to watch (see here: https://www.bloomberg.com/news/articles/2017-02-16/this-needle-cam-can-diagnose-joint-injuries-without-an-mri ). The Mi-Eye allows doctor's to immediately diagnose knee injuries by direct visualization via an "optical needle", thereby eliminating the trip to the MRI.

Vestagen protects Healthcare workers in NYC with Northwell Health

Vestagen protects Healthcare workers in NYC with Northwell Health

Vestagen Protective Technologies has begun supplying uniforms to Northwell Health, the largest hospital system in New York, with 60,000 healthcare workers. News outlets in New York City have given great coverage, including this from NY1 TV: http://www.ny1.com/nyc/all-boroughs/health-and-medicine/2017/02/22/germ-resistant-scrubs-gaining-traction-in-city-hospitals.html

HealthQuest joins Vesey Street in recapitalization of HealthChannels (ScribeAmerica)

HealthQuest joins Vesey Street in recapitalization of HealthChannels (ScribeAmerica)

Vesey Street Capital Partners, LLC (VSCP) today announced the completed recapitalization of HealthChannels (parent company of ScribeAmerica), a healthcare services organization with a full suite of solutions that enhances provider productivity, streamlines clerical processes and improves health outcomes. With 13,000 employees across 50 states and three countries, HealthChannels is uniquely positioned to help providers meet increased demands around mission-critical activities ranging from electronic medical records documentation to patient navigation, medical billing and coding. HealthQuest Capital and Heritage Group joined Vesey Street in the financing.

HealthQuest Leads Investment in Avizia

HealthQuest Leads Investment in Avizia

Avizia, the leading end to end telehealth solution provider, today announced the completion of its Series A financing totaling $17 million. The company raised an additional $6 million to supplement the initial $11 million, which was announced in July 2016. HealthQuest Capital led the additional round which included investment from strategic partner NewYork-Presbyterian. 

Trice Medical Receives FDA Clearance for MiEye2

Trice Medical Receives FDA Clearance for MiEye2

Trice Medical announced today that it received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for mi-eye 2, a disposable needle with a fully integrated camera that enables physicians to use advanced diagnostic imaging to visualize joint injuries in their clinic. 

HealthQuest leads $13.8M into Magnolia Medical

HealthQuest leads $13.8M into Magnolia Medical

Magnolia Medical Technologies, developer of the SteriPath® blood collection system and leader in improving the quality and accuracy of in-vitro diagnostic test results, today announced the closing of the company's $13.8 million Series B financing led by HealthQuest Capital. In conjunction with the financing, Garheng Kong, M.D., Ph.D., founder and managing partner of HealthQuest Capital will join the company's board.

Virmedica Expands Senior Management Team

Virmedica Expands Senior Management Team

VirMedica, the leader in providing e-access and specialty pharmacy technology solutions designed to expedite patient access to biopharmaceutical products, today announced the appointment of three new executives to the Company's senior leadership team. John J. Arcari has been appointed to chief financial officer (CFO) and will oversee the Company's financial operations. Richard Deyermond joins the company as vice president of client services and will lead teams engaged in the delivery of VirMedica's technology solutions. As the vice president of engineering, Elizabeth Ricci will focus on building out the Company's technology suite.

Virmedica Appoints Phil Lee as CEO

Virmedica Appoints Phil Lee as CEO

VirMedica, the leader in providing eACCESS technology solutions designed to expedite patient access to biopharmaceutical products, today announced that its Board of Directors has appointed Philip Lee as president, chief executive officer (CEO) and a member of the Board of Directors, effective immediately.

William A. Hawkins III Joins Trice Medical's Board of Directors

William A. Hawkins III Joins Trice Medical's Board of Directors

Trice Medical, an early stage medical device company, announced the appointment of William Hawkins to the company's board of directors, effective April 1, 2016. Hawkins joins a distinguished Board of proven industry leaders in their pursuit to revolutionize arthroscopic diagnostics. Mr. Hawkins is a renowned healthcare executive with diverse experience in healthcare delivery, innovation, and entrepreneurship.

HealthQuest Capital Closes Oversubscribed Fund at $225 Million

HealthQuest Capital Closes Oversubscribed Fund at $225 Million

HealthQuest Capital announced the closing of HealthQuest Capital II, LP, at the hard cap of $225 million and in excess of the initial fund target of $175 million. Investors in the fund include endowments, family offices, foundations, fund-of-funds, pension funds, and global healthcare organizations.

Read More

Spirox Inc. Raises Series C with HealthQuest and KKR

Spirox Inc. Raises Series C with HealthQuest and KKR

Spirox Inc., a privately held medical device company, announced today the closing of a $45 million Series C round of financing led by KKR, a leading global investment firm. Also participating in the financing is new investor HealthQuest Capital along with major existing shareholders Aisling Capital, Aperture Venture Partners and Venrock.

Read More

Vestagen raises $7M, appoints new CEO.

Vestagen raises $7M, appoints new CEO.

Orlando, Florida-based Vestagen Technical Textiles Inc, a medical technology company developing apparel for healthcare applications, raised $7 million in financing. Advent Life Sciences and HealthQuest Capital led the round, which was a planned extension of the company’s previous financing. Vestagen also named Bill Bold as chief executive officer. Bold replaces Dale Pfost, PhD, who was serving as interim CEO and remains chairman of the board.

Read More

 BioTheranostics Raises $32M from HealthQuest and Others

BioTheranostics Raises $32M from HealthQuest and Others

BioTheranostics, a leader in molecular diagnostics for cancer, today announced that it has closed a $32 million financing led by MVM Life Science Partners, with participation of Canepa Advanced Healthcare Fund and HealthQuest Capital. As a result of the financing, bioTheranostics will be spun out from bioMérieux, which will remain a minority shareholder, and operate as an independent company.

Read More